DE10082504D2 - Indikatorpeptid zur Diagnose und/oder Vorhersage von cardiovasculären und /oder endothelialen Erkrankungen, Antikörperzusammensetzung und immunoassay - Google Patents

Indikatorpeptid zur Diagnose und/oder Vorhersage von cardiovasculären und /oder endothelialen Erkrankungen, Antikörperzusammensetzung und immunoassay

Info

Publication number
DE10082504D2
DE10082504D2 DE10082504T DE10082504T DE10082504D2 DE 10082504 D2 DE10082504 D2 DE 10082504D2 DE 10082504 T DE10082504 T DE 10082504T DE 10082504 T DE10082504 T DE 10082504T DE 10082504 D2 DE10082504 D2 DE 10082504D2
Authority
DE
Germany
Prior art keywords
immunoassay
cardiovascular
prediction
diagnosis
antibody composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE10082504T
Other languages
English (en)
Other versions
DE10082504B4 (de
Inventor
Wolfgang Woloszczuk
Gerhard Hawa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Biomedica Wien GmbH
Original Assignee
Biomedica Wien GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biomedica Wien GmbH filed Critical Biomedica Wien GmbH
Publication of DE10082504D2 publication Critical patent/DE10082504D2/de
Application granted granted Critical
Publication of DE10082504B4 publication Critical patent/DE10082504B4/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/575—Hormones
    • G01N2333/58—Atrial natriuretic factor complex; Atriopeptin; Atrial natriuretic peptide [ANP]; Brain natriuretic peptide [BNP, proBNP]; Cardionatrin; Cardiodilatin

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Endocrinology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
DE10082504T 1999-08-20 2000-08-17 Verfahren, Immunoassay und Kit zur Vorhersage von cardiovasculären und /oder endothelialen Erkrankungen Expired - Fee Related DE10082504B4 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AT144499A AT407580B (de) 1999-08-20 1999-08-20 Indikatorpeptid zur diagnose und/oder vorhersage von cardiovasculären und/oder endothelialen erkrankungen, antikörperzusammensetzung und immunoassay
ATA1444/99 1999-08-20
PCT/AT2000/000224 WO2001014885A2 (de) 1999-08-20 2000-08-17 Indikatorpeptid zur diagnose und/oder vorhersage von cardiovasculären und/oder endothelialen erkrankungen, antikörperzusammensetzung und immunoassay

Publications (2)

Publication Number Publication Date
DE10082504D2 true DE10082504D2 (de) 2003-03-13
DE10082504B4 DE10082504B4 (de) 2009-05-07

Family

ID=3514025

Family Applications (1)

Application Number Title Priority Date Filing Date
DE10082504T Expired - Fee Related DE10082504B4 (de) 1999-08-20 2000-08-17 Verfahren, Immunoassay und Kit zur Vorhersage von cardiovasculären und /oder endothelialen Erkrankungen

Country Status (4)

Country Link
AT (1) AT407580B (de)
AU (1) AU6415000A (de)
DE (1) DE10082504B4 (de)
WO (1) WO2001014885A2 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030219734A1 (en) * 2001-04-13 2003-11-27 Biosite Incorporated Polypeptides related to natriuretic peptides and methods of their identification and use
ATE458199T1 (de) 2001-05-04 2010-03-15 Biosite Inc Diagnostische marker der akuten koronaren syndrome und ihre verwendungen
JP2005522669A (ja) 2001-08-20 2005-07-28 バイオサイト インコーポレイテッド 卒中および脳損傷の診断マーカーおよびその使用方法
US7608406B2 (en) 2001-08-20 2009-10-27 Biosite, Inc. Diagnostic markers of stroke and cerebral injury and methods of use thereof
US20050069549A1 (en) 2002-01-14 2005-03-31 William Herman Targeted ligands
US7919255B2 (en) 2003-06-17 2011-04-05 Otago Innovation Limited Assessment of skeletal growth using measurements of NT-CNP peptides
EP1577673B1 (de) * 2004-03-15 2008-07-30 F. Hoffmann-La Roche Ag Verwendung des BNP-Art und ANP-Art Peptiden für das Festsetzen der Gefahren von Herzgefäß- Komplikationen als Folge der Volumenüberlastung
EP2060920A1 (de) * 2007-11-19 2009-05-20 Biomedica Medizinprodukte GmbH & Co KG Diagnose von septischen Komplikationen
CA2680537C (en) 2007-03-12 2018-10-16 Soheyl Bahrami Diagnosis of septic complications
AT504943A1 (de) * 2007-03-12 2008-09-15 Biomedica Medizinprodukte Gmbh Diagnose septischer komplikationen
EP2883060B1 (de) * 2012-08-13 2018-03-21 Otago Innovation Limited Nt-procnp als biomarker für gefässerkrankungen und schwangerschaftskomplikationen
US10103357B2 (en) 2016-02-17 2018-10-16 The Curators Of The University Of Missouri Fabrication of multilayer nanograting structures
CN112710852B (zh) * 2021-03-26 2021-08-03 上海美迪西生物医药股份有限公司 一种gnp多肽的检测试剂盒及检测方法

Also Published As

Publication number Publication date
ATA144499A (de) 2000-08-15
WO2001014885A3 (de) 2002-02-14
DE10082504B4 (de) 2009-05-07
AT407580B (de) 2001-04-25
AU6415000A (en) 2001-03-19
WO2001014885A2 (de) 2001-03-01

Similar Documents

Publication Publication Date Title
DE10082504D2 (de) Indikatorpeptid zur Diagnose und/oder Vorhersage von cardiovasculären und /oder endothelialen Erkrankungen, Antikörperzusammensetzung und immunoassay
EP1141699A4 (de) Vorrichtungen und verfahren zum ausführen von blutgerinnungstesten mit piezoelektrischer detektion
WO2003070894A3 (en) A non-invasive diagnostic test utilizing histone modification markers
ATE230487T1 (de) Verfahren zur frühen diagnose von carcinomen
ATE464374T1 (de) Assay zum schnellen nachweis vom humanen aktivierten protein c und hochspezifischer monoklonaler antikörper dagegen
ATE301676T1 (de) Antikörper gegen die ed-b domäne von fibronektin, solche antikörper enthaltende konjugate, und deren verwendung zur diagnose und therapie von angiogenese-assoziierten tumoren und krankheiten
DE50304023D1 (de) Diagnose von Myokardinfarkt und akutem Koronarsyndrom durch Kombination von Markern
DE60223547D1 (de) Gangliosid-assoziierte rekombinante antikörper und deren verwendung bei der diagnose und behandlung von tumoren
ATE460430T1 (de) Kit zur untersuchung von menschlichem niedermolekulargewicht cd14 und antikörper
DE60129314D1 (de) Diagnose von leberfibrose mit hilfe von serummarkeralgorithmen
DE69531958D1 (de) (1-3)-beta-d-glukon-bindungsprotein, antikörper der dieses protein erkennt undverwendung des proteins und antikörper
BR9607854A (pt) Processos para a medição da taxa de degradação de uma proteína do corpo e para obtenção de informação referente à degradação de proteína em um paciente utilização de um isômero sintético de um peptídeo e de um anticorpo anticorpo capa de células análogo de peptídeo sintético e kit de análise para utilização em um processo de análise
ATE328281T1 (de) Methode zur diagnose von abnormalem knochenstoffwechsel
DK0946873T3 (da) Fremgangsmåde til diagnose af allergisk bronkopulmonal aspergillose
WO2001016184A3 (en) Diagnostic assay for type 2 heparin-induced thrombocytopenia
DE60133661D1 (de) Nachweismittel von patologischen veränderungen des proteins app und ihre verwendungen
WO2003027251A3 (en) Novel molecules of the pyrin domain protein family and uses thereof
DE69921987D1 (de) IMMUNTEST FÜR HUMAN CHROMOGRANINE A (CgA), ANTIKÖRPER, REAGENZ UND DAZU GEEIGNETER TESTSATZ
DE60136911D1 (de) Immunoassay und diagnostisches reagenz für malaria
ATE275268T1 (de) Verfahren zur diagnose von sjögren-syndrom
DE60222149D1 (de) Referenzkontrolle für hochempfindliche tests des c-reaktiven proteins
DE69800080D1 (de) Antikörper gegen das Prorenin Profragment, reninaktive Substanz die diese enthält und Prorenintest die diese verwendet
ATE184286T1 (de) Hgpiib-fragmente und ihre verwendung in in-vitro- verfahren zur bestimmung von in vivo stattfindenden thrombotischen ereignissen
DE59510146D1 (de) Antikörper für den Nachweis von Salmonellen
ATE309335T1 (de) Peptid für die diagnose von schizophrenie

Legal Events

Date Code Title Description
8110 Request for examination paragraph 44
8125 Change of the main classification

Ipc: G01N 3353

8364 No opposition during term of opposition
R119 Application deemed withdrawn, or ip right lapsed, due to non-payment of renewal fee

Effective date: 20140301